mifepristone and misoprostol induced abortion with a large myomatous uterus

Clicks: 250
ID: 163371
2005
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #84 of 196 articles by views in spermova

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 196 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Objective: To report the management of an early pregnancy with a large myomatous uterus. Case Report: A 34-year-old woman, with an unwanted pregnancy of 6 weeks' gestation and a large myomatous uterus, desired to terminate her pregnancy. She was first given three tablets of mifepristone 200 mg and three tablets of misoprostol 200 μg 48 hours later. However, this regimen did not produce an abortion, so five tablets of misoprostol 200 μg were placed into the posterior fornix of the vagina. The abortion was thus completed by the vaginal administration of 1,000 μg of misoprostol. Conclusion: Supplementary use of high-dose vaginal misoprostol may be considered as an alternative to terminate an early pregnancy in association with a myomatous uterus when the conventional combination of mifepristone and misoprostol fails.
Reference Key
li2005taiwanesemifepristone Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Yiu-Tai Li;Tsung-Cheng Kuo;Yi-Chih Chu;Shau-Chyi Hou
Journal spermova
Year 2005
DOI
10.1016/S1028-4559(09)60134-0
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.